News
2d
MedPage Today on MSNPulmonary Rehabilitation for COPD Pushes Forward"The science shows that there is greater benefit from pulmonary rehab than any pharmacology we can give a COPD patient, so a ...
2don MSN
Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...
People with COPD are vulnerable to small increases in PM2.5, with each 1 ÎĽg/m3 rise in long-term exposure linked to a 3.8% ...
Canadian wildfire smoke has entered the Upper Midwest and poses significant health impacts in the hardest-hit areas.
2d
MedPage Today on MSNEasing Airway Assaults in COPDFor COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...
Yet thanks to a new hospital-based educational and advocacy initiative for COPD patients, Croswell has been managing well at ...
Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.
Researchers warn of increased cannabis use among older US adults, as experts link it to health risks and complications in ...
For the many who first saw Edward Scissorhands in their youth, and for which it served as a gateway drug into the mind of Tim ...
In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...
5d
Pharmaceutical Technology on MSNSanofi and Regeneron report results from two Phase III trials of COPD treatmentSanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.
People who lost weight in midlife were less likely to experience heart attacks, strokes, cancer, asthma or chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results